| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | GA36S2O9C2 |
| InChI Key | ZXFRFPSZAKNPQQ-YTWAJWBKSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C13H21N5O2 |
| Molecular Weight | 279.34 |
| AlogP | 0.61 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 103.79 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 20.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Ligand-gated ion channel
Ionotropic glutamate receptor
AMPA receptor
|
- | 230-14000 | - | 2210-3200 | - | |
|
Ion channel
Ligand-gated ion channel
Ionotropic glutamate receptor
Kainate receptor
|
- | 230-31700 | - | 4160-4200 | 60 | |
|
Ion channel
Ligand-gated ion channel
Ionotropic glutamate receptor
NMDA receptor
|
- | 12100-61300 | - | - | 60 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Migraine Disorders | 2 | D008881 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 154652-83-2 |
| ChEMBL | CHEMBL14935 |
| DrugBank | DB06354 |
| FDA SRS | GA36S2O9C2 |
| Guide to Pharmacology | 4245 |
| PubChem | 23725095 |
| SureChEMBL | SCHEMBL1649338 |
| ZINC | ZINC000005134714 |
| CAS NUMBER | 154652-83-2 |
| ChEMBL | CHEMBL3989703 |
| FDA SRS | 6XN50U405Y |
| Guide to Pharmacology | 4245 |
| PubChem | 23725095 |